These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24756106)
1. ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression. de Sousa VP; Chaves CB; Huguenin JF; Moreira FC; de Reis BS; Chimelli L; Bergmann A; Simão Tde A; Pinto LF Cancer Biol Ther; 2014 Jul; 15(7):888-94. PubMed ID: 24756106 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma. Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma. Planagumà J; Liljeström M; Alameda F; Bützow R; Virtanen I; Reventós J; Hukkanen M Hum Pathol; 2011 Jan; 42(1):57-67. PubMed ID: 20970160 [TBL] [Abstract][Full Text] [Related]
4. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Planagumà J; Díaz-Fuertes M; Gil-Moreno A; Abal M; Monge M; García A; Baró T; Thomson TM; Xercavins J; Alameda F; Reventós J Cancer Res; 2004 Dec; 64(24):8846-53. PubMed ID: 15604243 [TBL] [Abstract][Full Text] [Related]
5. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma. Planagumà J; Gonzalez M; Doll A; Monge M; Gil-Moreno A; Baró T; García A; Xercavins J; Alameda F; Abal M; Reventós J Hum Pathol; 2006 Aug; 37(8):1050-7. PubMed ID: 16867868 [TBL] [Abstract][Full Text] [Related]
6. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886 [TBL] [Abstract][Full Text] [Related]
7. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Monge M; Colas E; Doll A; Gil-Moreno A; Castellvi J; Diaz B; Gonzalez M; Lopez-Lopez R; Xercavins J; Carreras R; Alameda F; Canals F; Gabrielli F; Reventos J; Abal M Carcinogenesis; 2009 Aug; 30(8):1288-97. PubMed ID: 19443906 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202 [TBL] [Abstract][Full Text] [Related]
10. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803 [TBL] [Abstract][Full Text] [Related]
11. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor. Mylonas I Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065 [TBL] [Abstract][Full Text] [Related]
12. Novel molecular profiles of endometrial cancer-new light through old windows. Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438 [TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma. Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983 [TBL] [Abstract][Full Text] [Related]
14. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer. Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607 [TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group. Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996 [TBL] [Abstract][Full Text] [Related]
16. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation. Peng WX; Kudo M; Fujii T; Teduka K; Naito Z Int J Clin Exp Pathol; 2014; 7(3):1069-76. PubMed ID: 24696723 [TBL] [Abstract][Full Text] [Related]
18. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma. Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146 [TBL] [Abstract][Full Text] [Related]
19. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma? Alvarez T; Miller E; Duska L; Oliva E Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825 [TBL] [Abstract][Full Text] [Related]
20. [The value of Ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer]. Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]